CD44 and brain cancer: initially demonstrated the efficacy of a label‐free and highly sensitive techniques in detecting and quantifying elevated levels of CD44 and CD133 in exosomes derived from brain cancer cells, which were immune captured from the blood and CSF of a mouse model with brain cancer.